Johnson & Johnson Nearing 52-Week High: Buy, Sell or Hold?

At $261.81, Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is a hold.

24/7 Wall Street • 11 hours ago

J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?

J&J's growth, new drug launches and pipeline strength support the stock, despite patent, MedTech and legal headwinds.

Zacks Investment Research • 15 hours ago

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14th, 2026. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will.

Business Wire • Aug 10, 2026

3 Beaten-Down Healthcare Stocks to Buy in August

Year to date, the healthcare sector finds itself in the middle of the S&P 500's pack.

24/7 Wall Street • Aug 10, 2026

Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.

Few companies have a longer track record of uninterrupted dividend growth. This streak is likely to be prolonged well into the foreseeable future.

The Motley Fool • Aug 9, 2026

Why PG, JNJ, and KO Could Surprise Investors Next Year

Defensive blue chips rarely dominate headlines, but heading into 2027, three of the market's most reliable dividend payers stand out as durable compounders.

24/7 Wall Street • Aug 8, 2026

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?

Zacks Investment Research • Aug 7, 2026

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

CNBC's Jim Cramer said earnings season reinforced five investing themes he thinks will produce the market's best buying opportunities. He highlighted stocks to buy for each theme, including Capital One, Ralph Lauren, Lam Research, CrowdStrike, Goldman Sachs and Eli Lilly.

CNBC • Aug 6, 2026

5 Solid Dividend Stocks to Buy in August

Volatility has been the theme of 2026. The VIX touched 31.05 in late March before settling back to a current reading of 15.86, and the 10-year Treasury yield sits at 4.70%, near the top of its 12-month range.

24/7 Wall Street • Aug 6, 2026

3 Dividend Stocks Built for Retirement to Buy in August

Retirement portfolios in August 2026 face a specific puzzle. Bond yields have come off their highs, equity valuations remain elevated, and the biggest secular story in markets, AI infrastructure, is dominated by expensive growth names that pay little or nothing in income.

24/7 Wall Street • Aug 5, 2026